For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.More than an estimated million Floridians are now using weight-loss medications, and experts believe that number will continue to rise
Decide your aliquot plan before the first opening, not after it
Log them in a tracking app before you eat them
This review focuses principally on GLP-1 RAs approved for treating both T2DM and obesity: liraglutide, semaglutide, and tirzepatide
Through Klinic's online platform, you can easily connect with qualified providers who can assess whether Contrave is right for you and provide a prescription if appropriate
If you keep up with all things aesthetic trends, you know that the age of GLP-1s has ushered in a whole new era of cosmetic treatment prioritiesmost notably, the so-called "Ozempic face." While the weight loss drugs in the GLP-1 category are beloved for their fat-burning capabilities, the facial volume loss that can accompany rapid weight loss has become a less-welcome side effect